CX3CL1 and cardiovascular disorder: According to a recent review conducted on the emerging role of FKN in treating rheumatoid diseases, E6011 was observed to subdue a significant contributor to inflammation and alleviate collateral fibrotic and cardiovascular diseases, which, in turn, makes E6011 a novel interventional approach to treating rheumatoid diseases.130